With automatic spending cuts nearing, lawmakers are calling for a review of policies they say have allowed businesses to profit on government research with limited return for taxpayers or consumers.
Seeking profit for taxpayers in potential of new drug
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.